MGNX - MacroGenics Inc logo

MGNX

MacroGenics Inc

MacroGenics, Inc. develops and commercializes antibody-based therapeutics for cancer treatment. Its pipeline includes bispecific molecules and antibody-drug conjugates targeting various solid tumors and hematological malignancies in clinical trials.

⚕️ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago $128today

Score Overview

1 Year
Score
Net Growth-11.43%
Net TrendShrank
Net Income Consistency
Rev Growth0.78%
Rev TrendGrew
Revenue Consistency
5 Years
Score4.7
Net Growth36.65%
Net Trend40%
Net Income Consistency
Rev Growth52.92%
Rev Trend60%
Revenue Consistency
10 Years
Score
Net Growth-270.51%
Net Trend50%
Net Income Consistency
Rev Growth48.23%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-284x
Net Trend50%
Net Income Consistency
Rev Growth163.42%
Rev Trend58%
Revenue Consistency

See the full market ranking →

MacroGenics Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 97M to $ 149M and net income went from -$ 117M to -$ 74M. Revenue increased in 3 of those 5 years; net income in 2.

Across MacroGenics Inc's full reported history, from 2013 to 2025, revenue grew from $ 56M to $ 149M and net income went from -$ 260.83K to -$ 74M. Revenue increased in 58% of the years measured; net income in 50%.

MacroGenics Inc currently holds a 5-year HDB Score of 4.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.02
1 Year2025-08-12
$ 1.47173.47%
5 Years2021-08-12
$ 24.50-83.59%
10 Years2016-08-12
$ 31.29-87.15%
All Time2013-10-10
$ 24.99-83.91%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 149M-$ 74M$ 189M
2024$ 148M-$ 66M$ 201M
2023$ 57M-$ 9M$ 229M
2022$ 151M-$ 120M$ 154M
2021$ 75M-$ 190M$ 243M
2020$ 97M-$ 117M$ 272M
2019$ 62M-$ 151M$ 215M
2018$ 60M-$ 171M$ 232M
2017$ 155M-$ 19M$ 305M
2016$ 86M-$ 58M$ 284M
2015$ 100M-$ 20M$ 339M
2014$ 47M-$ 38M$ 157M
IPO2013$ 56M-$ 260.83K$ 116M

Explore beyond MGNX

You're looking at MacroGenics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies